Drug Database
FL

fluorouracil + salicylic acid (Actikerall / LAS41005 / ADP18998)

✓ Approved

Cipher Pharmaceuticals, Inc. · 小分子 · 小分子

什么是 fluorouracil + salicylic acid?

fluorouracil + salicylic acid 是一种小分子,由Cipher Pharmaceuticals, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Topical。

药物档案

商品名Actikerall, LAS41005, ADP18998
公司Cipher Pharmaceuticals, Inc.
药物类别小分子
给药途径Topical
状态Approved

治疗适应症

fluorouracil + salicylic acid 针对 2 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Skin and subcutaneous tissue disordersActinic keratosis✓ Approved
Surgical and medical proceduresSkin neoplasm excisionPreclinical

相关研究文献

PubMedPlant physiology2026-11-19

Sugarcane mosaic virus HC-Pro-triggered hypersensitive cell death is modulated by interaction with P3N-PIPO.

Cheng Guangyuan G, Yang Zongtao Z, Chai Zhe Z, Liu Xingyu X et al.

Sugarcane mosaic virus (SCMV) causes heavy yield losses in both sugarcane and maize. However, the hypersensitive cell death (HCD) induced by SCMV helper component proteinase (HC-Pro), an RNA silencing suppressor (RSS), has not been characterized. Here, we show that transient expression of HC-Pro of sugarcane isolate (SCMVSc), but not HC-ProZm of maize isolate (SCMVZm), induces dose-dependent HCD in Nicotiana benthamiana and other plant species. HC-Pro-induced HCD is independent of salicylic acid, reactive oxygen species, and receptor kinases BAK1/SOBIR1, but dependent on Ca2+ influx and helper nucleotide-binding leucine-rich repeat receptors ADR1/N NRG1. The conserved F345 in HC-Pro is key to HCD induction, whereas the corresponding residue in HC-ProZm is Y345. HC-ProZmY345F induces HCD in N. benthamiana leaves. Correspondingly, SCMVZm-HC-ProY345F-GFP demonstrated markedly decreased infectivity on N. benthamiana and maize compared with SCMVZm-GFP. Furthermore, we show that the interaction between SCMVSc movement protein P3N-PIPO and HC-Pro enhances the RSS activity of HC-Pro and inhibits the intercellular diffusion of silencing signals and HC-Pro-induced HCD, and that the RSS activity of HC-Pro is not required for HCD induction. Together, these findings reveal that SCMV employs different strategies to circumvent HC-Pro-induced HCD in plants, shedding light on the co-evolution mechanisms between SCMV and its hosts sugarcane and maize.

PMID 43053684
阅读全文 →
PubMedPlant, cell & environment2026-11-19

Environmental Regulation of Secondary Metabolite Biosynthesis in Plants: Molecular Mechanisms, Ecological Adaptations and Biotechnological Prospects.

Sharma Nisha N, Ahlawat Yogesh K YK, Ponselvakumari Murugesan Kasthuribai MK, Kathula Karthika Vishnu Priya KVP et al.

Plants consistently come across a wide range of environmental obstacles that influence their growth, development and survival. The synthesis of specialised metabolites plays a vital role in defence and stress tolerance by plants. Specialised metabolites have a very close connection with primary metabolism via common precursors, energy, reducing power and the partitioning of carbon and nitrogen. Environmental stresses will result in a reprogramming of such interlinked metabolic pathways, which may cause changes in the production and storage of specialised metabolites as a possible response for acclimation and defence of plants. But this is not always helpful for plants under certain conditions. Biotic stresses (pathogenic infections) and microbial associations promote complex signalling pathways that activate plant defence mechanisms. These challenges often induce the accumulation of phytoalexins, phenolic compounds and other bioactive antimicrobial compounds through the stimulation of transcription factors and defence responsive genes. Hormone based signalling mediators (salicylic acid and ethylene), play a significant role in regulating these responses and facilitating metabolic activities associated in biosynthesis of secondary metabolites (SMs). Abiotic stresses (drought, salinity, temperature, radiations and heavy metals) also significantly affect SM production by inducing oxidative stress and inhibit cellular stability, leading to the initiation of antioxidant protection mechanism and triggers improved biosynthesis of SMs. The management of these metabolic pathways is regulated by stress induced genes, transcription factors and signal transduction frameworks including reactive oxygen species and hormone signalling interactions. This review focuses on the mechanisms of regulatory pathways directing the synthesis of SMs in plants under different environmental stresses. Current developments in Omics and molecular technologies, transcriptomics and metabolomics have provided greater understanding into the multifaceted regulatory networks mediating SM synthesis in plants. Conceptual understanding of these regulatory processes is essential for developing plant resilience and increased production of valuable plant derived compounds for various industrial applications. Overall, the regulation biosynthesis of SMs reflects a fundamental adaptive strategy that promotes plants to cope with environmental stress while assisting to ecological interactions and human health promoting benefits.

PMID 43053540
阅读全文 →
PubMedNPJ precision oncology2026-11-19

Shared evolutionary trajectories underlying carcinogenesis and metastasis in biliary tract cancer.

Kang Minsu M, Lee Ju Hyun JH, Na Hee Young HY, Kim Ji-Won JW et al.

The evolutionary dynamics of biliary tract cancer (BTC)-from precancerous transformation through metastatic dissemination and recurrence-remain poorly understood. We performed multi-regional and longitudinal whole-exome sequencing of 55 tumor specimens and 17 matched normals from 17 patients to reconstruct patient-specific phylogenetic trees and mutational signatures. TP53 (41.2%), KRAS (29.4%), and SMAD4 (23.5%) were the most frequently altered genes in primary tumors. Precancerous biliary intraepithelial neoplasia already harbored canonical driver mutations such as TP53 and KRAS, showing early branching and selective sweeps during malignant transition. During metastasis, distinct subclones expanded more than fivefold in 15 of 17 patients, frequently harboring driver-like alterations (e.g., NFKB1, MAPK7, PIK3C2A). Postoperative recurrences retained the phylogenetic structure of the primary tumor, supporting polyclonal rather than single-cell seeding. Mutational signatures associated with 5-fluorouracil (SBS17b) and platinum (SBS35) were enriched in recurrent/metastatic lesions, suggesting that chemotherapy may shape the tumor mutational landscape. Druggable targets-including ERBB2 amplification and KRAS mutations-were maintained through recurrence and metastasis when present at diagnosis. These findings reveal a consistent evolutionary program in BTC, encompassing early clonal diversification, subclonal expansion during metastasis, and polyclonal recurrence, underscoring the need for evolution-informed therapeutic strategies that address both clonal and subclonal alterations.

PMID 43052378
阅读全文 →
PubMedCancer immunology, immunotherapy : CII2026-11-19

Tumor-associated antigen-reactive T cells and clinical outcomes in head and neck squamous cell carcinoma treated with pembrolizumab plus chemotherapy.

Sato Ryosuke R, Sakaue Shota S, Ominato Hisataka H, Inoue Takahiro T et al.

Blood-based biomarkers associated with clinical outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with pembrolizumab plus chemotherapy remain poorly defined. We investigated 38 patients with HNSCC treated with pembrolizumab plus 5-fluorouracil and platinum (FP). Baseline systemic inflammation and immune status were assessed using routine laboratory parameters. Peripheral blood mononuclear cells were analyzed by flow cytometry to assess exhaustion- and activation-associated markers on CD4⁺ and CD8⁺ T cells, including CD38, Tim-3, PD-1, and ICOS. Tumor-associated antigen (TAA)-reactive immune responses were evaluated by interferon-γ production following stimulation with epidermal growth factor receptor (EGFR)- and c-Met-derived peptides. PD-L1 CPS positivity, elevated neutrophil-to-lymphocyte ratio, and higher frequencies of CD8⁺CD38⁺ T cells were associated with clinical outcomes, with similar trends observed for selected inflammatory and peripheral T-cell activation/exhaustion-associated markers. Tumor-associated antigen-reactive immune responses were detected in a subset of patients and were associated with prolonged progression-free survival, while EGFR peptide reactivity was additionally associated with improved overall survival. In this exploratory study, immune reactivity to TAAs was associated with favorable clinical outcomes in patients receiving pembrolizumab plus FP. Together with systemic inflammation and peripheral T-cell activation/exhaustion markers, these findings support further evaluation of integrated blood-based immune profiling, including TAA-reactive immune responses, as candidate biomarkers in larger prospective cohorts.

PMID 43052553
阅读全文 →
PubMedAnimal microbiome2026-11-19

Dose-dependent microbiome, metabolome and lipidome shifts in a mouse model of colitis-associated colorectal cancer using azoxymethane and dextran sodium sulphate.

Van Dingenen Lena L, Segers Charlotte C, Mysara Mohamed M, Osang'ir Bernard Isekah BI et al.

Colorectal cancer (CRC) remains a major health burden, underscoring the need for continued research to improve screening methods and treatment outcomes. The colitis-associated azoxymethane (AOM) and dextran sodium sulphate (DSS) mouse model has proven valuable for CRC research, as it closely mimics human CRC development and captures the complex interactions between the gut microbiome and immune system. However, variations in AOM/DSS dosing reported in literature can influence baseline conditions, thereby affecting the outcome and interpretation of experimental and therapeutic interventions. This study evaluated the impact of varying AOM and DSS doses on CRC development and the gut microbiome, metabolome and lipidome in mouse faeces (n = 29). Inflammation-driven CRC progression was more pronounced in mice treated with high-dose AOM (12.5 mg/kg) combined with high-dose DSS (2%) than in those receiving lower doses. Faecal 16S rRNA-based microbiome analysis revealed significant shifts in the high-dose AOM groups, which coincided with the highest tumour burden. Operational taxonomic units (OTUs) belonging to Prevotella, Turicibacter, Intestinimonas and Akkermansia muciniphila displayed patterns linked to inflammation and tumour progression, with distinct temporal abundance increases across AOM/DSS dosing groups. State-of-the-art, validated UHPLC-HRMS methodologies for faecal metabolomics and lipidomics fingerprinting (7951 features) and profiling (202 targets) identified imidazolepropionic acid, a microbe-derived metabolite, as a candidate biomarker associated with inflammation-driven CRC. In addition, mice with a high tumour burden presented elevated levels of lactic acid and γ-glutamylphenylalanine as well as decreased levels of fumaric acid, 6-deoxygalactose, glucosamine/mannosamine and L-threonine, all of which are associated with gut barrier dysfunction and inflammation. Furthermore, there was a decreased abundance of a short-chain acylcarnitine and both odd-chain and even-chain fatty acids, suggesting that altered energy metabolism may be associated with CRC progression. Multi-omics integration revealed a factor shaped by differential contributions from metabolites and lipids linked to Lachnospiraceae spp., with compounds like lactic acid, methylmalonic acid, linoleic acid and palmitoleic acid positively associated with inflammation and CRC, while hypoxanthine, nicotinic acid/2-picolinic acid, L-carnitine and deoxycarnitine, showed potential protective associations. These findings highlight the complex interplay between gut inflammation, microbiome dynamics and metabolic reprogramming in CRC and suggest that AOM/DSS dosing substantially influences these interactions.

PMID 43053245
阅读全文 →
PubMedJournal of translational medicine2026-11-19

Metabolic remodeling in early- and late-onset colorectal cancer supports an age-informed detection model.

Wang Ruowei R, Wang Weifeng W, Liao Leen L, Zheng Muxu M et al.

The incidence of early-onset colorectal cancer (EOCRC) has increased in recent decades; however, most metabolomic studies have focused on all age groups. Consequently, it remains uncertain how metabolic alterations drive EOCRC progression and whether biomarker signatures identified in older patients are valid in younger populations. We performed untargeted plasma metabolomic profiling of 791 participants, including those with colorectal cancer (CRC), colorectal adenoma (CRA), and healthy controls. Individuals were stratified by age (<50 and ≥50 years) to explore metabolic remodeling during EOCRC and late-onset CRC (LOCRC) development. A multistep feature selection process and 12 machine learning algorithms were used to establish an age-informed CRC detection model. CRC progression was associated with the suppression of caffeine and histidine metabolism and the enhancement of amino acid metabolism, particularly branched-chain amino acid, glycine-serine, and arginine-proline pathways. EOCRC showed increased phenylalanine, butanoate, and lipoic acid metabolism, whereas LOCRC was enriched in purine and fatty acid biosynthesis. A 7-metabolite panel (caffeine, ergothioneine, hypoxanthine 1, L-valyl-L-alanine, L-seryl-L-aspartic acid, cholic acid, and cycloleucine) was trained and achieved excellent detection values in all age groups (AUC > 0.95). SHapley Additive exPlanations (SHAP) analysis highlighted metabolite-specific contributions, supporting biological interpretability. These findings delineate age-related metabolic remodeling in CRC and demonstrate that integrating plasma metabolomics with machine learning supports a robust and interpretable non-invasive detection approach. The proposed age-informed model may inform future age-tailored CRC detection strategies amid the increasing burden of early-onset cancers.

PMID 43053157
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多fluorouracil + salicylic acid